Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 442

1.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN.

Nature. 2006 Dec 7;444(7120):756-60. Epub 2006 Oct 18.

PMID:
17051156
2.

Targeting brain-tumor stem cells.

Stupp R, Hegi ME.

Nat Biotechnol. 2007 Feb;25(2):193-4. No abstract available.

PMID:
17287755
3.

Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.

Zhou W, Sun M, Li GH, Wu YZ, Wang Y, Jin F, Zhang YY, Yang L, Wang DL.

Oncol Rep. 2013 Oct;30(4):1793-801. doi: 10.3892/or.2013.2614. Epub 2013 Jul 11.

PMID:
23846672
4.

Comparative analysis of DNA repair in stem and nonstem glioma cell cultures.

Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, Poggi A, Cappelli E, Zona G, Spaziante R, Corte G, Frosina G.

Mol Cancer Res. 2009 Mar;7(3):383-92. doi: 10.1158/1541-7786.MCR-08-0409. Epub 2009 Mar 10.

5.

CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.

McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ.

Clin Cancer Res. 2009 Aug 15;15(16):5145-53. doi: 10.1158/1078-0432.CCR-09-0263. Epub 2009 Aug 11.

6.

Glioblastoma and stem cells.

Altaner C.

Neoplasma. 2008;55(5):369-74. Review.

PMID:
18665745
7.

Cancer: stem cells and brain tumours.

Dirks PB.

Nature. 2006 Dec 7;444(7120):687-8. No abstract available.

PMID:
17151644
8.

The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.

Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ.

Neoplasia. 2012 Feb;14(2):150-8.

9.

Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.

Wang W, Long L, Wang L, Tan C, Fei X, Chen L, Huang Q, Liang Z.

Cancer Lett. 2016 Feb 28;371(2):274-84. doi: 10.1016/j.canlet.2015.12.012. Epub 2015 Dec 17.

PMID:
26706414
10.

Notch promotes radioresistance of glioma stem cells.

Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA.

Stem Cells. 2010 Jan;28(1):17-28. doi: 10.1002/stem.261.

11.

BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery.

Facchino S, Abdouh M, Chatoo W, Bernier G.

J Neurosci. 2010 Jul 28;30(30):10096-111. doi: 10.1523/JNEUROSCI.1634-10.2010.

12.

IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.

Chen Y, Zhang F, Tsai Y, Yang X, Yang L, Duan S, Wang X, Keng P, Lee SO.

Radiat Oncol. 2015 Nov 14;10:227. doi: 10.1186/s13014-015-0534-1.

13.

CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.

Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, Tsai YF, Ho JH, Lee CH, Lee OK.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):61-71. doi: 10.1007/s00259-012-2242-5. Epub 2012 Oct 19.

14.

Radioresistant glioma stem cells--therapeutic obstacle or promising target?

Chalmers AJ.

DNA Repair (Amst). 2007 Sep 1;6(9):1391-4. Epub 2007 May 7. Review.

PMID:
17482890
15.

Chk1 knockdown confers radiosensitization in prostate cancer stem cells.

Wang X, Ma Z, Xiao Z, Liu H, Dou Z, Feng X, Shi H.

Oncol Rep. 2012 Dec;28(6):2247-54. doi: 10.3892/or.2012.2068. Epub 2012 Oct 1.

PMID:
23027394
16.

Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.

Annabi B, Lachambre MP, Plouffe K, Sartelet H, BĂ©liveau R.

Mol Carcinog. 2009 Oct;48(10):910-9. doi: 10.1002/mc.20541.

PMID:
19326372
17.

Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.

Garcia JL, Perez-Caro M, Gomez-Moreta JA, Gonzalez F, Ortiz J, Blanco O, Sancho M, Hernandez-Rivas JM, Gonzalez-Sarmiento R, Sanchez-Martin M.

BMC Cancer. 2010 Aug 24;10:454. doi: 10.1186/1471-2407-10-454.

18.

Targeting cancer stem cells through L1CAM suppresses glioma growth.

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.

Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079.

19.

Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.

Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.

J Neurosurg. 2011 Mar;114(3):651-62. doi: 10.3171/2009.11.JNS091396. Epub 2010 Nov 5.

PMID:
21054139
20.

Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.

Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, Ellis JA, Kang J, Assanah M, McKhann GM, Sisti MB, McCormick PC, Canoll P, Bruce JN.

Neurosurgery. 2008 Feb;62(2):505-14; discussion 514-5. doi: 10.1227/01.neu.0000316019.28421.95.

PMID:
18382330

Supplemental Content

Support Center